poisar

Stocks · News reference

Quanterix Expands Access to Blood-Based Alzheimer's Testing Through Partnership with Sherman Abrams Laboratory

Fiscal.ai

Quanterix Corporation has entered into an exclusive distribution agreement with Sherman Abrams Laboratory to provide its LucentAD® Complete blood tests to patients in New Jersey and the surrounding region.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Quanterix Corp (QTRX)

    Filed: 2026-11-18 AccNo: 0001503274-26-000051 Size: 162 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

  2. BenzingaEarnings Transcripts

    Quanterix Q3 2026 Earnings Call Transcript

    Quanterix (NASDAQ:QTRX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For